Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

LLongeveron Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
L

Longeveron Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • Longeveron Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)
    Sep 16, 2026Longeveron Press Releases
  • Longeveron to Present at the H.C. Wainwright 28th Annual Global Investment Conference
    Sep 3, 2026Longeveron Press Releases
  • Longeveron Announces 1-for-10 Reverse Stock Split
    Aug 24, 2026Longeveron Press Releases
  • Longeveron Appoints Nirav Jhaveri as Chief Financial Officer
    Aug 19, 2026Longeveron Press Releases
  • Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update
    Aug 12, 2026Longeveron Press Releases
  • Longeveron Named a Finalist Team and Will Receive a $1,000,000 Milestone 2 Award for the XPRIZE Healthspan Global Competition
    Aug 11, 2026Longeveron Press Releases
  • Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026
    Aug 3, 2026Longeveron Press Releases
  • Deborah D. Ascheim, M.D. Elected to Longeveron Board of Directors
    Jul 23, 2026Longeveron Press Releases
  • Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer’s Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in Patients with Alzheimer’s Disease
    Jul 13, 2026Longeveron Press Releases
  • Longeveron® Appoints Marie Washburn as Chief Financial Officer
    Jul 6, 2026Longeveron Press Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$2.72Close · Sep 22, 2026